Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Jimenez

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Neuro-Oncology|June 18, 2025
Quality of life in pediatric patients treated with adjuvant proton radiation for craniopharyngiomasMelanie L Rose, Benjamin V M Bajaj, Rachel Jimenez, et al.
JCO Oncology Practice|November 12, 2024
Ethical and Clinical Considerations in Ordering and Responding to Molecular Diagnostics and Circulating Tumor DNA as the Science EvolvesKathryn DeCarli, Angela Bradbury, Ana Maria Lopez, et al.
Canadian Medical Education Journal|March 8, 2021
Exploring the perceived educational impact of COVID-19 on postgraduate training in oncology: impact of self-determination and resilienceMeredith Giuliani, Diana Samoil, Ankit Agarwal, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 6, 2020
The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US populationKassidy Beyerlin, Rachel Jimenez, Mark Zangardi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast CancerLaura Spring, Rachel Greenup, Andrzej Niemierko, et al.
Cancer|October 10, 2024
Financial toxicity in early-phase cancer clinical trial participantsSienna M Durbin, Debra Lundquist, Andrea Pelletier, et al.
Journal of Geriatric Oncology|March 19, 2026
Cardiac risk, outcomes, and management among older adults with stage I-II non-small cell lung cancer undergoing stereotactic body radiation therapyLeah L Thompson, Sanjana B Shah, Austin T Gregg, et al.
Breast Cancer Research and Treatment|September 17, 2018
Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancerLaura Spring, Andrzej Niemierko, Stephanie Haddad, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2026
Associations of symptom burden with patient-reported outcomes and clinical outcomes among early phase cancer clinical trial participantsAnh B Lam, Andrea Pelletier, Sienna M Durbin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2017
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline UpdateCatherine Van Poznak, Mark R Somerfield, William E Barlow, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Neuro-Oncology|June 18, 2025
Quality of life in pediatric patients treated with adjuvant proton radiation for craniopharyngiomasMelanie L Rose, Benjamin V M Bajaj, Rachel Jimenez, et al.
JCO Oncology Practice|November 12, 2024
Ethical and Clinical Considerations in Ordering and Responding to Molecular Diagnostics and Circulating Tumor DNA as the Science EvolvesKathryn DeCarli, Angela Bradbury, Ana Maria Lopez, et al.
Canadian Medical Education Journal|March 8, 2021
Exploring the perceived educational impact of COVID-19 on postgraduate training in oncology: impact of self-determination and resilienceMeredith Giuliani, Diana Samoil, Ankit Agarwal, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 6, 2020
The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US populationKassidy Beyerlin, Rachel Jimenez, Mark Zangardi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast CancerLaura Spring, Rachel Greenup, Andrzej Niemierko, et al.
Cancer|October 10, 2024
Financial toxicity in early-phase cancer clinical trial participantsSienna M Durbin, Debra Lundquist, Andrea Pelletier, et al.
Journal of Geriatric Oncology|March 19, 2026
Cardiac risk, outcomes, and management among older adults with stage I-II non-small cell lung cancer undergoing stereotactic body radiation therapyLeah L Thompson, Sanjana B Shah, Austin T Gregg, et al.
Breast Cancer Research and Treatment|September 17, 2018
Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancerLaura Spring, Andrzej Niemierko, Stephanie Haddad, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2026
Associations of symptom burden with patient-reported outcomes and clinical outcomes among early phase cancer clinical trial participantsAnh B Lam, Andrea Pelletier, Sienna M Durbin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2017
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline UpdateCatherine Van Poznak, Mark R Somerfield, William E Barlow, et al.
Pageof 4